Final Debarment Order: Rahim Shafa; Denial of Hearing
The DEA has issued a final debarment order against Rahim Shafa, denying a hearing, which prohibits him from participating in any capacity in DEA-regulated activities, including dispensing controlled substances.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmacies and other DEA registrants that may have employed or contracted with Rahim Shafa. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate, as the order is final.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Rahim Shafa is now formally debarred from participating in any capacity in DEA-regulated activities, meaning pharmacies cannot employ him in roles involving controlled substances.
Who it affects
Pharmacies and other DEA registrants that may have employed or contracted with Rahim Shafa.
What you must do
Review current and past employment or contractor relationships with Rahim Shafa and ensure he is not involved in any controlled-substance-related activities.
Deadline
Immediate, as the order is final.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Thomas Earley, D.D.S.; Decision and Order
- Appeals court says Arkansas can enforce dispensing fee rule on PBMs - Arkansas Advocate
- Abortion Exceptionalism: How the New Louisiana Law Classifying Medication Abortion as a “Controlled Substance” Compromises Health Care - National Partnership for Women & Families
- Guidance: Compounding Animal Drugs from Bulk Drug Substances: Compounding under CGMP in Federally-Registered Facilities
- Decision and Order: Atlantic Treatment Center, LLC